Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-05

Clinical Trial Update: Trial Liposomal Bupivacaine Following Retropubic Suburethral Sling for Stress Urinary Incontinence [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating liposomal bupivacaine following retropubic suburethral sling for stress urinary incontinence has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: TriHealth Inc. | Conditions: Urinary Incontinence, Stress | Phase 4 | Status: COMPLETED | Results posted: 2018-03-05